Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment With Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Class II Risk Alleles and Have an Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 15 de sept de 2021
ID: NCT04909801
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Osteoarthritis Knee Pain, and Obesity or Overweight (ENLIGHTEN-4)
INTERVENTIONAL
Inicio: 9 de feb de 2026
ID: NCT07353931
Por invitación
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Open-label, Single-arm, Extension Study to Evaluate the Long-term Safety and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy
INTERVENTIONAL
Inicio: 30 de jul de 2024
ID: NCT06475742
Completado
ClinicalTrials.gov
Changes in Cytokines After Masked Intraarticular Injection of Dextrose or Aspiration Only in Stage IV Knee Osteoarthritis
INTERVENTIONAL
Inicio: 1 de ago de 2018
ID: NCT03400631
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy
INTERVENTIONAL
Inicio: 6 de ago de 2012
ID: NCT01606761
Reclutando
Fase 3
ClinicalTrials.gov
SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects With Moderately to Severely Active SLE
INTERVENTIONAL
Inicio: 19 de jul de 2023
ID: NCT05843643
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00089804
Completado
ClinicalTrials.gov
Retrospective Cohort Study of Rebif® Use in Pediatric MS Patients
OBSERVATIONAL
Inicio: 1 de jul de 2010
ID: NCT01207648
Completado
ClinicalTrials.gov
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis Receiving Treatment With Non- Steroidal Anti- Inflammatory Drugs.
OBSERVATIONAL
Inicio: 1 de may de 2012
ID: NCT01577563
Terminado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo Controlled, Parallel Group, Multi-center, Phase III Trial of Ofatumumab Investigating Clinical Efficacy in Patients With Active Rheumatoid Arthritis Who Have Previously Had an Inadequate Response to One or More TNF Antagonist Therapies
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00603525
Completado
Fase 3
ClinicalTrials.gov
A 24 Week Randomized, Double-blind, Placebo-controlled Withdrawal Trial With a 16 Week Open-label lead-in Phase, and 64 Week Open-label Follow-up, to Evaluate the Effect on Clinical Response and the Safety of Tocilizumab in Patients With Active Polyarticular-course Juvenile Idiopathic Arthritis
INTERVENTIONAL
Inicio: 30 de nov de 2009
ID: NCT00988221
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 25 de oct de 2023
ID: NCT06025578
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
INTERVENTIONAL
Inicio: 18 de oct de 2021
ID: NCT05092269
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo Controlled, Single-dose Study to Assess the Initial Efficacy of Canakinumab (ACZ885) With Respect to the Adapted ACR Pediatric 30 Criteria in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00886769
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam (7.5, 15, and 22.5 mg) and Placebo in Patients With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de jun de 2002
ID: NCT00042068
Desconocido
ClinicalTrials.gov
Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
OBSERVATIONAL
Inicio: 1 de jun de 2019
ID: NCT04534647
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de mar de 2018
ID: NCT03312907
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo Controlled, Withdrawal Study of Flare Prevention of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations
INTERVENTIONAL
Inicio: 1 de jul de 2009
ID: NCT00889863
Reclutando
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 7 de nov de 2021
ID: NCT05003934
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Intravenously, in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de sept de 2006
ID: NCT00361335
Anterior
1
...
17
18
19
...
434
Siguiente
Filtros